Fairfield Financial Advisors, LTD
- SEC CIK
- 0002033232
- Latest filing
- Aug 11, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Fairfield Financial Advisors, LTD, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,008
- Value
- $454.4K
- % of portfolio
- 0.2%
- Quarters held
- 17
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,008 | $454.4K | 0.2% | −2,149−30.0% | Reduced | Holders |
| Q1 2026 | 7,157 | $734.8K | 0.3% | −843−10.5% | Reduced | Holders |
| Q4 2025 | 8,000 | $1.00M | 0.3% | +680+9.3% | Added | Holders |
| Q3 2025 | 7,320 | $980.5K | 0.3% | +98+1.4% | Added | Holders |
| Q2 2025 | 7,222 | $982.3K | 0.3% | −2,587−26.4% | Reduced | Holders |
| Q1 2025 | 9,809 | $1.30M | 0.5% | −6,354−39.3% | Reduced | Holders |
| Q4 2024 | 16,163 | $1.83M | 0.6% | −6,646−29.1% | Reduced | Holders |
| Q3 2024 | 22,809 | $2.60M | 0.9% | −7,934−25.8% | Reduced | Holders |
| Q2 2024 | 30,743 | $3.19M | 1.1% | – | No prior filing | Holders |
| Q1 2024 | – | – | – | – | Not filed | Holders |
| Q4 2023 | 44,915 | $4.94M | 1.9% | −7,752−14.7% | Reduced | Holders |
| Q3 2023 | 52,667 | $5.10M | 2.1% | −3,490−6.2% | Reduced | Holders |
| Q2 2023 | 56,157 | $6.12M | 2.4% | −1,506−2.6% | Reduced | Holders |
| Q1 2023 | 57,663 | $5.71M | 2.5% | −1,271−2.2% | Reduced | Holders |
| Q4 2022 | 58,934 | $6.47M | 3.0% | −3,913−6.2% | Reduced | Holders |
| Q3 2022 | 62,847 | $6.08M | 2.9% | +56+0.1% | Added | Holders |
| Q2 2022 | 62,791 | $6.82M | 3.2% | −4,788−7.1% | Reduced | Holders |
| Q1 2022 | 67,579 | $8.00M | 2.9% | – | No prior filing | Holders |